BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,090 filers reported holding BAXTER INTL INC in Q2 2021. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $559,496 | -23.2% | 14,825 | -7.3% | 0.23% | -24.3% |
| Q2 2023 | $728,960 | +11.3% | 16,000 | -0.9% | 0.30% | +16.9% |
| Q1 2023 | $655,044 | -22.4% | 16,150 | -2.5% | 0.26% | -18.7% |
| Q4 2022 | $844,318 | -3.3% | 16,565 | +2.2% | 0.32% | -17.1% |
| Q3 2022 | $873,000 | -16.1% | 16,215 | 0.0% | 0.39% | -6.7% |
| Q2 2022 | $1,041,000 | -19.8% | 16,215 | -3.1% | 0.42% | -8.2% |
| Q1 2022 | $1,298,000 | -13.4% | 16,737 | -4.2% | 0.45% | -16.6% |
| Q4 2021 | $1,499,000 | +6.8% | 17,462 | 0.0% | 0.54% | +0.7% |
| Q3 2021 | $1,404,000 | +1.0% | 17,462 | +1.2% | 0.54% | +5.5% |
| Q2 2021 | $1,390,000 | -6.1% | 17,262 | -1.7% | 0.51% | -7.9% |
| Q1 2021 | $1,481,000 | +3.7% | 17,562 | -1.3% | 0.55% | -6.1% |
| Q4 2020 | $1,428,000 | -1.3% | 17,792 | -1.1% | 0.59% | -10.3% |
| Q3 2020 | $1,447,000 | -6.6% | 17,992 | 0.0% | 0.66% | -12.7% |
| Q2 2020 | $1,549,000 | +6.0% | 17,992 | 0.0% | 0.75% | -6.5% |
| Q1 2020 | $1,461,000 | -4.6% | 17,992 | -1.7% | 0.81% | +18.4% |
| Q4 2019 | $1,531,000 | -3.7% | 18,312 | +0.8% | 0.68% | -6.8% |
| Q3 2019 | $1,589,000 | +6.5% | 18,162 | -0.3% | 0.73% | +8.5% |
| Q2 2019 | $1,492,000 | +0.7% | 18,212 | 0.0% | 0.67% | +1.5% |
| Q1 2019 | $1,481,000 | +20.2% | 18,212 | -2.7% | 0.66% | +10.5% |
| Q4 2018 | $1,232,000 | -14.6% | 18,712 | 0.0% | 0.60% | +0.8% |
| Q3 2018 | $1,443,000 | +3.4% | 18,712 | -1.1% | 0.60% | -0.5% |
| Q2 2018 | $1,396,000 | +13.5% | 18,912 | 0.0% | 0.60% | +17.5% |
| Q1 2018 | $1,230,000 | -1.4% | 18,912 | -2.1% | 0.51% | +6.7% |
| Q4 2017 | $1,248,000 | +0.6% | 19,312 | -2.3% | 0.48% | -3.0% |
| Q3 2017 | $1,240,000 | +0.3% | 19,762 | -3.2% | 0.49% | -1.0% |
| Q2 2017 | $1,236,000 | +0.2% | 20,412 | -14.1% | 0.50% | -0.4% |
| Q1 2017 | $1,233,000 | +16.8% | 23,772 | -0.2% | 0.50% | +12.6% |
| Q4 2016 | $1,056,000 | -2.0% | 23,822 | -0.1% | 0.44% | -6.7% |
| Q3 2016 | $1,078,000 | 0.0% | 23,837 | 0.0% | 0.48% | +0.6% |
| Q2 2016 | $1,078,000 | +9.7% | 23,837 | -0.4% | 0.47% | +18.2% |
| Q1 2016 | $983,000 | +15.5% | 23,937 | +7.4% | 0.40% | +15.6% |
| Q4 2015 | $851,000 | +16.7% | 22,297 | +0.5% | 0.35% | +8.8% |
| Q3 2015 | $729,000 | -66.8% | 22,197 | -29.3% | 0.32% | -62.9% |
| Q2 2015 | $2,196,000 | +2.8% | 31,397 | +0.6% | 0.86% | +5.5% |
| Q1 2015 | $2,137,000 | -7.4% | 31,197 | -1.0% | 0.81% | -8.7% |
| Q4 2014 | $2,308,000 | +2.1% | 31,497 | 0.0% | 0.89% | +3.7% |
| Q3 2014 | $2,261,000 | -2.2% | 31,497 | -1.4% | 0.86% | +1.8% |
| Q2 2014 | $2,311,000 | -1.7% | 31,959 | 0.0% | 0.84% | -5.4% |
| Q1 2014 | $2,352,000 | +6.9% | 31,959 | +1.0% | 0.89% | +7.4% |
| Q4 2013 | $2,200,000 | +15.3% | 31,639 | +8.9% | 0.83% | +9.7% |
| Q3 2013 | $1,908,000 | -5.2% | 29,047 | 0.0% | 0.76% | -9.6% |
| Q2 2013 | $2,012,000 | – | 29,047 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |